Received Oct 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y017527 | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z005455 | — |
No additional AE; the MMR II, VARIVAX and the HAVRIX vaccines were intended for another patient in the room; a 5 week old female patient was supposed to receive the ENGERIX- B vaccine and a healthcare worker inadvertently administered the patient the MMR II, VARIVAX and HAVRIX vaccines concomitantly; This spontaneous report was received from a medical assistant and refers to a 5-week-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-OCT-2025, the patient was supposed to receive hepatitis b vaccine rhbsag (yeast) (ENGERIX B) (dose, route of administration, anatomical location, lot# and expiry date were not reported) for prophylaxis, however, a healthcare worker inadvertently vaccinated the patient with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, lot #Y017527, expiration date: 21-OCT-2026 (dose, route of administration and anatomical location were not reported), with varicella virus vaccine live (oka-merck) (VARIVAX) injection, lot #Z005455, expiration date: 04-MAR-2027 (dose, route of administration and anatomical location were not reported), and with hepatitis a vaccine inact (HAVRIX) (dose, route of administration, anatomical location, lot# and expiry date were not reported) (Wrong product administered); measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka-merck) (VARIVAX) were reconstituted with sterile diluent (lot# and expiry date were not reported). It was reported that varicella virus vaccine live (oka-merck) (VARIVAX), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and hepatitis a vaccine inact (HAVRIX) were intended for another patient in the room (Wrong patient received product). No additional adverse event was reported (No adverse event).